Media Summary: Dr Samuel Klempner, MD from Massachusetts General Hospital discusses the current question of what to do with Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of a retrospective analysis of a real-world cohort ... Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

A Positive Ctdna Test After - Detailed Analysis & Overview

Dr Samuel Klempner, MD from Massachusetts General Hospital discusses the current question of what to do with Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of a retrospective analysis of a real-world cohort ... Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment. Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses For more info, visit: This video explores Signatera, a personalized blood ...

Photo Gallery

A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI
Real-world monitoring of ctDNA reliably predicts cancer recurrence in resected stages I-III CRC
Understand ctDNA Testing
The prognostic value of ctDNA-based MRD testing in lymphoma
Circulating Tumor DNA Updates in Breast Cancer
What is Circulating Tumor DNA (ctDNA)?
Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute
Limitations of ctDNA analysis in predicting recurrence of GI malignancies
What is a CtDNA Test? (and my results from it)
Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?
The Signatera Test
2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum
Sponsored
Sponsored
View Detailed Profile
A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI

A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI

Dr Samuel Klempner, MD from Massachusetts General Hospital discusses the current question of what to do with

Real-world monitoring of ctDNA reliably predicts cancer recurrence in resected stages I-III CRC

Real-world monitoring of ctDNA reliably predicts cancer recurrence in resected stages I-III CRC

Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of a retrospective analysis of a real-world cohort ...

Sponsored
Understand ctDNA Testing

Understand ctDNA Testing

Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

The prognostic value of ctDNA-based MRD testing in lymphoma

The prognostic value of ctDNA-based MRD testing in lymphoma

Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of

Circulating Tumor DNA Updates in Breast Cancer

Circulating Tumor DNA Updates in Breast Cancer

Let's talk about

Sponsored
What is Circulating Tumor DNA (ctDNA)?

What is Circulating Tumor DNA (ctDNA)?

For more info, visit: https://www.primrmed.com/cancer/general

Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute

Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute

Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses

Limitations of ctDNA analysis in predicting recurrence of GI malignancies

Limitations of ctDNA analysis in predicting recurrence of GI malignancies

Patients may present with

What is a CtDNA Test? (and my results from it)

What is a CtDNA Test? (and my results from it)

I took a

Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?

Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?

Can a blood

The Signatera Test

The Signatera Test

For more info, visit: https://www.primrmed.com/cancer/commercial-products This video explores Signatera, a personalized blood ...

2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

2025 HOPA Conference: Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

Learning Objectives: Describe

Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis

Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis

The blood-based